186 related articles for article (PubMed ID: 34105809)
1. Sequencing of myeloma therapy: Finding the right path among many standards.
Rajkumar SV
Hematol Oncol; 2021 Jun; 39 Suppl 1():68-72. PubMed ID: 34105809
[No Abstract] [Full Text] [Related]
2. Multiple myeloma: Every year a new standard?
Rajkumar SV
Hematol Oncol; 2019 Jun; 37 Suppl 1(Suppl 1):62-65. PubMed ID: 31187526
[TBL] [Abstract][Full Text] [Related]
3. Emerging options for combination therapy in multiple myeloma.
Rossi AC
Clin Adv Hematol Oncol; 2018 Mar; 16(3):192-194. PubMed ID: 29742074
[No Abstract] [Full Text] [Related]
4. Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma.
Marneni N; Chakraborty R
Curr Hematol Malig Rep; 2021 Apr; 16(2):148-161. PubMed ID: 33876390
[TBL] [Abstract][Full Text] [Related]
5. Multiple Myeloma: Clinical Updates From the American Society of Hematology Annual Meeting 2018.
Terpos E; Ntanasis-Stathopoulos I;
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e324-e336. PubMed ID: 31076371
[TBL] [Abstract][Full Text] [Related]
6. Real-world treatment patterns and outcomes in non-transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom.
Mohty M; Knauf W; Romanus D; Corman S; Verleger K; Kwon Y; Cherepanov D; Cambron-Mellott MJ; Vikis HG; Gonzalez F; Gavini F; Ramasamy K
Eur J Haematol; 2020 Sep; 105(3):308-325. PubMed ID: 32418256
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma.
Demonchy J; Cordier C; Fréalle E; Demarquette H; Herbaux C; Escure G; Willaume A; Van De Wyngaert Z; Noel MP; Facon T; Faure K; Caro J; Morgan G; Davies FE; Alfandari S; Bories C; Boyle EM
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e545-e547. PubMed ID: 33642203
[No Abstract] [Full Text] [Related]
8. MRD Assessment in Multiple Myeloma: Progress and Challenges.
Bertamini L; D'Agostino M; Gay F
Curr Hematol Malig Rep; 2021 Apr; 16(2):162-171. PubMed ID: 33950462
[TBL] [Abstract][Full Text] [Related]
9. Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups.
Afram G; Susek KH; Uttervall K; Wersäll JD; Wagner AK; Luong V; Lund J; Gahrton G; Alici E; Nahi H
Eur J Haematol; 2021 Apr; 106(4):546-554. PubMed ID: 33471414
[TBL] [Abstract][Full Text] [Related]
10. The clonal evolution during long-term clinical course of multiple myeloma.
Mishima Y; Mishima Y; Shirouchi Y; Nishimura N; Yokoyama M; Okabe T; Inoue N; Uryu H; Fukuta T; Hatake K; Terui Y
Int J Hematol; 2021 Feb; 113(2):279-284. PubMed ID: 32864713
[TBL] [Abstract][Full Text] [Related]
11. Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma.
Bruno AS; Willson JL; Opalinska JM; Nelson JJ; Lunacsek OE; Stafkey-Mailey DR; Willey JP
Expert Rev Hematol; 2020 Sep; 13(9):1017-1025. PubMed ID: 32844683
[TBL] [Abstract][Full Text] [Related]
12. Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies.
Cohen AD; Garfall AL; Dogan A; Lacey SF; Martin C; Lendvai N; Vogl DT; Spear M; Lesokhin AM
Blood Adv; 2019 Aug; 3(16):2487-2490. PubMed ID: 31451444
[TBL] [Abstract][Full Text] [Related]
13. Current Review on High-Risk Multiple Myeloma.
Chan HSH; Chen CI; Reece DE
Curr Hematol Malig Rep; 2017 Apr; 12(2):96-108. PubMed ID: 28317082
[TBL] [Abstract][Full Text] [Related]
14. Management of high-risk Myeloma: an evidence-based review of treatment strategies.
Lehners N; Hayden PJ; Goldschmidt H; Raab MS
Expert Rev Hematol; 2016 Aug; 9(8):753-65. PubMed ID: 27337562
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for multiple myeloma in the era of novel therapies.
Ziogas DC; Dimopoulos MA; Kastritis E
Expert Rev Hematol; 2018 Nov; 11(11):863-879. PubMed ID: 30334460
[TBL] [Abstract][Full Text] [Related]
16. The Association between Metabolic Syndrome and Multiple Myeloma.
Ragbourne SC; Maghsoodi N; Streetly M; Crook MA
Acta Haematol; 2021; 144(1):24-33. PubMed ID: 32408305
[TBL] [Abstract][Full Text] [Related]
17. When to recommend a second autograft in patients with relapsed myeloma?
Ziogas DC; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2017 Apr; 58(4):781-787. PubMed ID: 27894207
[TBL] [Abstract][Full Text] [Related]
18. How to Think About Risk in Myeloma.
Krishnan A
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S135-8. PubMed ID: 27521310
[TBL] [Abstract][Full Text] [Related]
19. Progress in the Management of Smoldering Multiple Myeloma.
Schmidt TM; Callander NS
Curr Hematol Malig Rep; 2021 Apr; 16(2):172-182. PubMed ID: 33983517
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma: diagnosis and treatment.
Rajkumar SV; Kyle RA
Mayo Clin Proc; 2005 Oct; 80(10):1371-82. PubMed ID: 16212152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
